This high-capacity research combination vial contains Retatrutide (20mg) and Tirzepatide (40mg) co-lyophilized in a single sealed vial. The blend combines a dual GIP/GLP-1 receptor agonist (Tirzepatide) with a triple GIP/GLP-1/glucagon receptor agonist (Retatrutide), offering researchers a concentrated, multi-compound format for advanced incretin receptor pharmacology studies. Heartland Bio Labs supplies this combination as a lyophilized research compound with individual purity verification for each component.
Retatrutide 20mg + Tirzepatide 40mg (Combination Blend)
- ≥99% HPLC
- Mass Spec Verified
- COA Per Lot
- US Lab
This high-capacity research combination vial contains Retatrutide (20mg) and Tirzepatide (40mg) co-lyophilized in a single sealed vial. The blend combines a dual GIP/GLP-1 receptor agonist (Tirzepatide) with a triple GIP/GLP-1/glucagon receptor agonist (Retatrutide), offering researchers a concentrated, multi-compound format for advanced incretin receptor pharmacology studies. Heartland Bio Labs supplies this combination as a lyophilized research compound with individual purity verification for each component.
Same-day shipping if you order today
The combination of Retatrutide and Tirzepatide in a single formulation supports research protocols examining multi-receptor incretin pathway interactions or comparative receptor agonism studies. Tirzepatide acts on GIP and GLP-1 receptors, while Retatrutide adds glucagon receptor co-agonism. This blend is relevant for advanced metabolic research programs investigating the overlapping and additive pharmacology of incretin-class compounds across receptor systems.
This compound is supplied strictly for research purposes. No clinical or therapeutic application is implied or represented.
Product Characteristics
- Blend composition: Retatrutide (triple GIP/GLP-1/glucagon agonist) + Tirzepatide (dual GIP/GLP-1 agonist)
- Format: Co-lyophilized dual-compound blend in a single high-capacity research vial
- Appearance: White to off-white lyophilized powder
- Reconstitution medium: Bacteriostatic water or sterile water (research standard)
| Purity | ≥99% HPLC |
|---|
Handling Information
Handle under standard laboratory conditions with appropriate PPE. Reconstitute with appropriate sterile media. Avoid repeated freeze-thaw cycles. Each compound is also available individually in the Heartland Bio Labs catalog. This compound is intended for qualified research use only.
Storage Requirements
- Long-term (lyophilized): Store at -20°C, protected from light and moisture
- Short-term (reconstituted): Store at 4°C; use within 28 days
- Keep in original sealed vial until point of use
Customer reviews coming soon. Be the first to share your research experience.
How should I store this peptide?+
Lyophilized peptides should be stored at −20°C in a dry, light-protected environment. Avoid repeated freeze-thaw cycles. Once reconstituted, store at 2-8°C and use within 4-8 weeks depending on the compound.
What should I reconstitute it with?+
Bacteriostatic water or sterile water for research use. We recommend our companion BAC Water for consistency. Specific reconstitution volume depends on your research protocol — refer to the Specifications tab for solubility data.
How quickly do orders ship?+
Orders confirmed before 2:00 PM CT ship the same business day from our facility in Tulsa, OK. Standard US transit is 2-5 business days. Tracking provided at shipment.
Is the COA verified independently?+
Yes. Every lot is tested by HPLC for purity (target ≥99%) and mass spectrometry for molecular identity before release. The COA is generated from the actual lot data, not a generic template.
Can I get bulk or institutional pricing?+
Yes — qualified research facilities and high-volume orders receive tiered pricing. Contact us with your institution information and target quantities.
Every lot is independently verified — HPLC purity, mass spec identity, lot number, storage parameters. Click below to view or download.
Look up COA in portal →Customer Reviews
Customer reviews coming soon. Be the first to share your research experience.
